MB DNA Studija Finance - revenue, profit
EBITDA margin (%)
Register and
explore Okredo dataEBIT margin (%)
Register and
explore Okredo dataFinancial statement report
Price: €9.90
Premium users: 1.00 credit
Premium users: 1.00 credit
Indicator |
---|
Turnover (€) |
Sales per employee (€) |
Profit before tax (€) |
Net Profit (€) |
Profit per employee (€) |
Total profitability (%) |
Net profitability (%) |
Equity (€) |
Amounts Payable And Liabilities (€) |
Non-current Assets (€) |
CurrentAssets (€) |
Working capital requirement |
Debt-to-equity ratio |
EBITDA margin (%) |
EBITDA (€) |
EBIT margin (%) |
EBIT (€) |
2022 |
---|
168,109 |
168,109 |
-3,293 |
-3,612 |
-3,612 |
52.46 |
-2.15 |
8,529 |
130,523 |
23,383 |
115,669 |
2023 |
---|
134,150 |
- |
-1,176 |
-1,181 |
- |
45.30 |
-0.88 |
7,348 |
76,882 |
21,046 |
63,184 |
2024 |
---|
169,035 |
- |
662 |
604 |
- |
45.69 |
0.36 |
7,952 |
53,538 |
16,454 |
45,036 |
Register and
explore Okredo dataRegister and
explore Okredo data2024
Turnover (€)
169,035 €26 % *
Sales per employee (€)
-Profit before tax (€)
662 €156 % *
Net Profit (€)
604 €151 % *
Profit per employee (€)
-Total profitability (%)
45.69 %0.86 % *
Net profitability (%)
0.36 %140.91 % *
Equity (€)
7,952 €8 % *
Amounts Payable And Liabilities (€)
53,538 €-30 % *
Non-current Assets (€)
16,454 €-22 % *
CurrentAssets (€)
45,036 €-29 % *